PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 75.95% | 108.24% | 330.52% | 317.65% | 49.23% |
| Total Receivables | 28.40% | 51.97% | 11.00% | 7.68% | 0.27% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 74.85% | 106.90% | 1,404.24% | 1,361.14% | 14.35% |
| Total Current Assets | 63.95% | 94.04% | 169.27% | 161.22% | 32.55% |
|
|
|||||
| Total Current Assets | 63.95% | 94.04% | 169.27% | 161.22% | 32.55% |
| Net Property, Plant & Equipment | 61.76% | 91.47% | 51.35% | 46.82% | -2.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.59% | 2.27% | -4.47% | -7.33% | -4.32% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 55.79% | 84.38% | 146.10% | 138.74% | 26.00% |
|
|
|||||
| Total Accounts Payable | 21.57% | 43.88% | 53.38% | 48.79% | 5.51% |
| Total Accrued Expenses | 8.63% | 28.55% | -59.82% | -61.02% | 17.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.83% | 26.47% | 74.73% | 69.46% | 24.77% |
| Total Finance Division Other Current Liabilities | -- | -- | -95.91% | -96.03% | -- |
| Total Other Current Liabilities | -- | -- | -95.91% | -96.03% | -- |
| Total Current Liabilities | 19.67% | 41.63% | 8.61% | 5.37% | 7.26% |
|
|
|||||
| Total Current Liabilities | 19.67% | 41.63% | 8.61% | 5.37% | 7.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 241.66% | 304.37% | 484.93% | 467.28% | -46.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 30.42% | 54.41% | 52.46% | 47.85% | 91.50% |
| Total Liabilities | 25.31% | 48.30% | 17.03% | 13.53% | 5.86% |
|
|
|||||
| Common Stock & APIC | 32.92% | 57.31% | 65.00% | 60.06% | 25.36% |
| Retained Earnings | -23.62% | -46.31% | -32.25% | -28.29% | -19.74% |
| Treasury Stock & Other | 1.17% | 19.74% | -0.05% | -3.04% | -29.85% |
| Total Common Equity | 68.31% | 99.20% | 190.79% | 182.10% | 33.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 68.31% | 99.20% | 190.79% | 182.10% | 33.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -69.18% | -63.52% | -19.12% | -21.54% | 40.66% |
| Total Equity | 64.81% | 95.05% | 185.68% | 177.13% | 33.51% |
|
|
|||||